CA2480550A1 - Improving performance of an analyte monitoring device - Google Patents
Improving performance of an analyte monitoring device Download PDFInfo
- Publication number
- CA2480550A1 CA2480550A1 CA002480550A CA2480550A CA2480550A1 CA 2480550 A1 CA2480550 A1 CA 2480550A1 CA 002480550 A CA002480550 A CA 002480550A CA 2480550 A CA2480550 A CA 2480550A CA 2480550 A1 CA2480550 A1 CA 2480550A1
- Authority
- CA
- Canada
- Prior art keywords
- microprocessors
- analyte
- glucose
- measured charge
- signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/681—Wristwatch-type devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7242—Details of waveform analysis using integration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0531—Measuring skin impedance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
Abstract
The present invention comprises one or more microprocessors programmed to execute methods for improving the performance of an analyte monitoring device including prediction of glucose levels in a subject by utilizing a predicted slower-time constant (1/k2). In another aspect of the invention, pre-exponential terms (1/c2) can be used to provide a correction for signal decay (e.g., a Gain Factor). In other aspects, the present invention relates to one or more microprocessors comprising programming to control execution of (i) methods for conditional screening of data points to reduce skipped measurements, (ii) methods for qualifying interpolated/extrapolated analyte measurement values, (iii) various integration methods to obtain maximum integrals of analyte-related signals, as well as analyte monitoring devices comprising such microprocessors. Further, the present invention relates to algorithms for improved optimization of parameters for use in prediction models that require optimization of adjustable parameters.
Claims (67)
1. One or more microprocessors, comprising programming to control obtaining a measured charge signal over time, comprising a measured charge signal response curve specifically related to the amount or concentration of the glucose extracted from the subject, wherein said measured charge signal response curve comprises a kinetic region;
using (i) a mathematical model as presented in Eq. (3A) wherein "Q" represents the charge, "t" represents the elapsed time, "S o" is a fitted parameter, "c1" and "c2" are pre-exponential terms that correspond to the electric current contribution at t=0 for first and second reactions, respectively, "k1"
and "k2" are rate constants for the first and second reactions, respectively, and (ii) an error minimization method, to iteratively estimate values of parameters S o, c1, c2, k1, and k2 using said model and error minimization method to fit a predicted response curve to said kinetic region of said measured charge signal response curve, wherein (a) the error minimization method provides a calculated error based on differences between kinetic regions of said predicted and measured charge signal response curves and (b) said estimating is iteratively performed until the calculated error between the predicted and measured charge signal response curves is minimized or until no further statistically significant change is seen in the calculated error, at which time iterative estimation of the parameters is stopped, said iterative estimation and error minimization results in estimated values of said parameters; and correlating 1/k2 with a glucose amount or concentration to provide a measurement of the amount or concentration of the glucose in the subject.
using (i) a mathematical model as presented in Eq. (3A) wherein "Q" represents the charge, "t" represents the elapsed time, "S o" is a fitted parameter, "c1" and "c2" are pre-exponential terms that correspond to the electric current contribution at t=0 for first and second reactions, respectively, "k1"
and "k2" are rate constants for the first and second reactions, respectively, and (ii) an error minimization method, to iteratively estimate values of parameters S o, c1, c2, k1, and k2 using said model and error minimization method to fit a predicted response curve to said kinetic region of said measured charge signal response curve, wherein (a) the error minimization method provides a calculated error based on differences between kinetic regions of said predicted and measured charge signal response curves and (b) said estimating is iteratively performed until the calculated error between the predicted and measured charge signal response curves is minimized or until no further statistically significant change is seen in the calculated error, at which time iterative estimation of the parameters is stopped, said iterative estimation and error minimization results in estimated values of said parameters; and correlating 1/k2 with a glucose amount or concentration to provide a measurement of the amount or concentration of the glucose in the subject.
2. The one or more microprocessors of claim 1, further programmed to control operating a sensing device for obtaining a measured charge signal over time.
3. The one or more microprocessors of claim 1, further programmed to control a measurement cycle comprising (a) operating a sampling device for extracting a sample from the subject, said sample comprising glucose, and (b) operating a sensing device for obtaining a measured charge signal over time.
4. The one or more microprocessors of claim 3, further programmed to perform a series of measurement cycles resulting in a series of measured charge signal response curves.
5. The one or more microprocessors of claim 4, wherein after estimation of each predicted response curve for each measured charge signal response curve in the series of measurements an amount or concentration of the glucose is determined based on each estimated parameter 1/k2.
6. The one or more microprocessors of any of claims 1-5, wherein correlating 1/k2 with a glucose amount or concentration to provide a measurement of the amount or concentration of glucose is performed by a method comprising applying a calibration value.
7. The one or more microprocessors of claim 6, wherein said correlating is carried out as follows:
where Glu t is glucose concentration at time t, Glu cal is glucose concentration at a time of calibration that corresponds to an estimated 1/k2 at the time of calibration, and (1/k2)t is the estimated 1/k2 at time t.
where Glu t is glucose concentration at time t, Glu cal is glucose concentration at a time of calibration that corresponds to an estimated 1/k2 at the time of calibration, and (1/k2)t is the estimated 1/k2 at time t.
8. The one or more microprocessors of any of claims 1-7, wherein said measured charge signal response curve was obtained by integration of a measured current signal response curve, and said one or more microprocessors are further programmed to control said integration.
9. The one or more microprocessors of claim 8, wherein before said integration is performed, said one or more microprocessors are further programmed to control a background subtraction correction of the measured current signal response curve.
10. The one or more microprocessors of claim 9, wherein said obtaining comprises extracting a sample comprising said glucose from the subject into a collection reservoir using a sampling device to obtain a concentration of the glucose in said reservoir and said one or more microprocessors are programmed to control operation of said sampling device.
11. The one or more microprocessors of claim 10, wherein the collection reservoir is in contact with a skin or mucosal surface of the subject and the glucose is extracted across said skin or mucosal surface.
12. The one or more microprocessors of claim 11, wherein glucose is extracted using an iontophoretic current applied to said skin or mucosal surface.
13. The one or more microprocessors of claim 12, wherein the collection reservoir comprises an enzyme that reacts with the extracted glucose to produce an electrochemically detectable signal.
14. The one or more microprocessors of claim 13, wherein the enzyme comprises glucose oxidase.
15. The one or more microprocessors of claim 13, wherein said electrochemically detectable signal is peroxide, said signal is detected at a reactive surface of a biosensor electrode, said detecting is accomplished using a sensing device, and said one or more microprocessors are further programmed to control operation of said sensing device.
16. The one or more microprocessors of claim 15, wherein said kinetic region of said measured charge signal response curve corresponds to a measurement time period of 0 to about 180 seconds.
17. An analyte monitoring system, comprising the one or more microprocessors of any of claims 1, 2; 6, 7, 8, or 9, and the sensing device used to obtain said measured charge signal response curve.
18. An analyte monitoring system, comprising the one or more microprocessors of any of claims 3, 4, 5, 8, 9, or 10-16;
the sampling device; and the sensing device used to obtain said measured charge signal response curve.
the sampling device; and the sensing device used to obtain said measured charge signal response curve.
19. The monitoring system of claim 18, wherein the sampling device comprises a laser device.
20. The monitoring system of claim 18, wherein the sampling device comprises a sonophoretic device.
21. The monitoring system of claim 18, wherein the sampling device comprises an iontophoretic device.
22. A method of providing a glucose amount or concentration in a subject comprising obtaining a measured charge signal over time, comprising a measured charge signal response curve specifically related to the amount or concentration of the glucose extracted from the subject, wherein said measured charge signal response curve comprises a kinetic region;
using (i) a mathematical model as presented in Eq.(3A) wherein "Q" represents the charge, "t" represents the elapsed time, "S o" is a fitted parameter, "c1" and "c2" are pre-exponential terms that correspond to the electric current contribution at t=0 for first and second reactions, respectively, "k1"
and "k2" are rate constants for the first and second reactions, respectively, and (ii) an error minimization method, to iteratively estimate values of parameters S o, c1, c2, k1, and k2 using said model and error minimization method to fit a predicted response curve to said kinetic region of said measured charge signal response curve, wherein (a) the error minimization method provides a calculated error based on differences between kinetic regions of said predicted and measured charge signal response curves, and (b) said estimating is iteratively performed until the calculated error between the predicted and measured charge signal response curves is minimized or until no further statistically significant change is seen in the calculated error, at which time iterative estimation of the parameters is stopped, said iterative estimation and error minimization results in estimated values of said parameters; and correlating 1/k2 with a glucose amount or concentration to provide a measurement of the amount or concentration of the glucose in the subject.
using (i) a mathematical model as presented in Eq.(3A) wherein "Q" represents the charge, "t" represents the elapsed time, "S o" is a fitted parameter, "c1" and "c2" are pre-exponential terms that correspond to the electric current contribution at t=0 for first and second reactions, respectively, "k1"
and "k2" are rate constants for the first and second reactions, respectively, and (ii) an error minimization method, to iteratively estimate values of parameters S o, c1, c2, k1, and k2 using said model and error minimization method to fit a predicted response curve to said kinetic region of said measured charge signal response curve, wherein (a) the error minimization method provides a calculated error based on differences between kinetic regions of said predicted and measured charge signal response curves, and (b) said estimating is iteratively performed until the calculated error between the predicted and measured charge signal response curves is minimized or until no further statistically significant change is seen in the calculated error, at which time iterative estimation of the parameters is stopped, said iterative estimation and error minimization results in estimated values of said parameters; and correlating 1/k2 with a glucose amount or concentration to provide a measurement of the amount or concentration of the glucose in the subject.
23. One or more microprocessors, comprising programming to control obtaining a measured charge signal over time using an electrochemical sensor, said measured charge signal comprising a measured charge signal response curve specifically related to an amount or concentration of glucose extracted from a subject, wherein said measured charge signal response curve comprises a kinetic region;
using (i) a mathematical model as presented in Eq.(3A) wherein "Q" represents the charge, "t" represents the elapsed time, "S o" is a fitted parameter, "c1" and "c2" are pre-exponential terms that correspond to the electric current contribution at t=0 for first and second reactions, respectively, "k1"
and "k2" are rate constants for the first and second reactions, respectively, and (ii) an error minimization method, to iteratively estimate values of parameters S o, c1, c2, k1, and k2 using said model and error minimization method to fit a predicted response curve to said kinetic region of said measured charge signal response curve, wherein (a) the error minimization method provides a calculated error based on differences between kinetic regions of said predicted and measured charge signal response curves, and (b) said estimating is iteratively performed until the calculated error between the predicted and measured charge signal response curves is minimized or until no further statistically significant change is seen in the calculated error, at which time iterative estimation of the parameters is stopped, said iterative estimation and error minimization results in estimated values of said parameters; and correcting for signal decay of the electrochemical sensor by multiplying the measured charge signal by a gain factor estimated from 1/c2.
using (i) a mathematical model as presented in Eq.(3A) wherein "Q" represents the charge, "t" represents the elapsed time, "S o" is a fitted parameter, "c1" and "c2" are pre-exponential terms that correspond to the electric current contribution at t=0 for first and second reactions, respectively, "k1"
and "k2" are rate constants for the first and second reactions, respectively, and (ii) an error minimization method, to iteratively estimate values of parameters S o, c1, c2, k1, and k2 using said model and error minimization method to fit a predicted response curve to said kinetic region of said measured charge signal response curve, wherein (a) the error minimization method provides a calculated error based on differences between kinetic regions of said predicted and measured charge signal response curves, and (b) said estimating is iteratively performed until the calculated error between the predicted and measured charge signal response curves is minimized or until no further statistically significant change is seen in the calculated error, at which time iterative estimation of the parameters is stopped, said iterative estimation and error minimization results in estimated values of said parameters; and correcting for signal decay of the electrochemical sensor by multiplying the measured charge signal by a gain factor estimated from 1/c2.
24. The one or more microprocessors of claim 23, further programmed to control operating a sensing device for obtaining a measured charge signal over time.
25. The one or more microprocessors of claim 23, further programmed to control a measurement cycle comprising (a) operating a sampling device for extracting a sample from the subject, said sample comprising glucose and (b) operating a sensing device for obtaining a measured charge signal over time.
26. The one or more microprocessors of claim 25, further programmed to perform a series of measurement cycles resulting in a series of measured charge signal response curves.
27. The one or more microprocessors of claim 26, wherein after estimation of each predicted response curve for each measured charge signal response curve in the series of measurements, said one or more microprocessors are further programmed to determine a gain factor on each estimated parameter 1/c2 and multiply each gain factor by the measured charge signal corresponding to the predicted response curve from which the gain factor was estimated.
28. The one or more microprocessor of claim 27, wherein said series of measurements comprise measured charge signal response curves at times t, t-1, t-2, etc.
29. The one or more microprocessor of claim 28, further programmed to normalize and/or smooth two or more gain factors from the series of measurements to obtain a normalized and/or smoothed gain factor, and correct for signal decay of the electrochemical sensor by multiplying the measured charge signal at time t by said normalized and/or smoothed gain factor.
30. The one or more microprocessor of claim 29, wherein the series comprises at least five measured charge signal response curves, and said normalized and/or smoothed gain factor is calculated based on (1/c2)t, (1/c2)t-1, (1/c2)t-2, (1/c2)t-3, and (1/c2)t-4.
31. The one or more microprocessors of any of claims 23-30, wherein said measured charge signal response curve was obtained by integration of a measured current signal response curve, and said one or more microprocessors are further programmed to control said integration.
32. The one or more microprocessors of claim 31, wherein before said integration is performed said one or more microprocessors are further programmed to control a background subtraction correction of the measured current signal response curve.
33. The one or more microprocessors of claim 32, wherein said obtaining comprises extracting a sample comprising said glucose from the subject into a collection reservoir using a sampling device to obtain a concentration of the glucose in said reservoir and said one or more microprocessors are programmed to control operation of said sampling device.
34. The one or more microprocessors of claim 33, wherein the collection reservoir is in contact with a skin or mucosal surface of the subject and the glucose is extracted across said skin or mucosal surface.
35. The one or more microprocessors of claim 34, wherein glucose is extracted using an iontophoretic current applied to said skin or mucosal surface.
36. The one or more microprocessors of claim 35, wherein the collection reservoir comprises an enzyme that reacts with the extracted glucose to produce an electrochemically detectable signal.
37. The one or more microprocessors of claim 36, wherein the enzyme comprises glucose oxidase.
38. The one or more microprocessors of claim 37, wherein said electrochemically detectable signal is peroxide, said signal is detected at a reactive surface of the electrochemical sensor, said detecting is accomplished using a sensing device, and said one or more microprocessors are further programmed to control operation of said sensing device.
39. The one or more microprocessors of claim 38, wherein said kinetic region of said measured charge signal response curve corresponds to a measurement time period of 0 to about 180 seconds.
40. An analyte monitoring system, comprising the one or more microprocessors of any of claims 23, 24; or 31, and the sensing device used to obtain said measured charge signal response curve.
41. An analyte monitoring system, comprising the one or more microprocessors of any of claims 25-39;
the sampling device; and the sensing device used to obtain said measured charge signal response curve.
the sampling device; and the sensing device used to obtain said measured charge signal response curve.
42. The monitoring system of claim 41, wherein the sampling device comprises a laser device.
43. The monitoring system of claim 41, wherein the sampling device comprises a sonophoretic device.
44. The monitoring system of claim 41, wherein the sampling device comprises an iontophoretic device.
45. A method of correcting for signal decay of an electrochemical sensor used for the detection of an amount or concentration of glucose in a subject, said method comprising obtaining a measured charge signal over time using said electrochemical sensor, said measured charge signal comprising a measured charge signal response curve specifically related to the amount or concentration of glucose extracted from the subject, wherein said measured charge signal response curve comprises a kinetic region;
using (i) a mathematical model as presented in Eq.(3A) wherein "Q" represents the charge, "t" represents the elapsed time, "S o" is a fitted parameter, "c1" and "c2" are pre-exponential terms that correspond to the electric current contribution at t=0 for first and second reactions, respectively, "k1"
and "k2" are rate constants for the first and second reactions, respectively, and (ii) an error minimization method, to iteratively estimate values of parameters S o, c1, c2, k1, and k2 using said model and error minimization method to fit a predicted response curve to said kinetic region of said measured charge signal response curve, wherein (a) the error minimization method provides a calculated error based on differences between kinetic regions of said predicted and measured charge signal response curves, and (b) said estimating is iteratively performed until the calculated error between the predicted and measured charge signal response curves is minimized or until no further statistically significant change is seen in the calculated error, at which time iterative estimation of the parameters is stopped, said iterative estimation and error minimization results in estimated values of said parameters; and correcting for signal decay of the electrochemical sensor by multiplying the measured charge signal by a gain factor estimated from 1/c2.
using (i) a mathematical model as presented in Eq.(3A) wherein "Q" represents the charge, "t" represents the elapsed time, "S o" is a fitted parameter, "c1" and "c2" are pre-exponential terms that correspond to the electric current contribution at t=0 for first and second reactions, respectively, "k1"
and "k2" are rate constants for the first and second reactions, respectively, and (ii) an error minimization method, to iteratively estimate values of parameters S o, c1, c2, k1, and k2 using said model and error minimization method to fit a predicted response curve to said kinetic region of said measured charge signal response curve, wherein (a) the error minimization method provides a calculated error based on differences between kinetic regions of said predicted and measured charge signal response curves, and (b) said estimating is iteratively performed until the calculated error between the predicted and measured charge signal response curves is minimized or until no further statistically significant change is seen in the calculated error, at which time iterative estimation of the parameters is stopped, said iterative estimation and error minimization results in estimated values of said parameters; and correcting for signal decay of the electrochemical sensor by multiplying the measured charge signal by a gain factor estimated from 1/c2.
46. One or more microprocessors, comprising programming to control providing a measurement value related to glucose amount or concentration in a subject, a skin conductance reading associated in time with said glucose measurement value, and one or more further data integrity screens associated with said glucose measurement value; and accepting said measurement value when either (i) said skin conductance reading and said one or more further data integrity screens fall within predetermined acceptable ranges or within predetermined threshold values, or (ii) said skin conductance reading falls outside of predetermined acceptable range or beyond predetermined threshold value and said one or more further data integrity screens fall within predetermined acceptable ranges or with predetermined threshold values, or skipping said measurement value when said skin conductance reading falls outside of predetermined acceptable range or beyond predetermined threshold value and one or more of said one or more further data integrity screens fall outside of predetermined acceptable ranges or beyond predetermined threshold values.
47. The one or more microprocessors of claim 46, wherein said one or more further data integrity screens is selected from the group consisting of peak sensor current and background current.
48. An analyte monitoring system comprising, said one or more microprocessors of any of claims 46-47;
a sensing device used to provide said measurement value related to glucose amount or concentration; and a skin conductance measurement device used to provide said skin conductance reading, wherein said one or more microprocessors are further programmed to control operation of said sensing device and said skin conductance measurement device.
a sensing device used to provide said measurement value related to glucose amount or concentration; and a skin conductance measurement device used to provide said skin conductance reading, wherein said one or more microprocessors are further programmed to control operation of said sensing device and said skin conductance measurement device.
49. One or more microprocessors, comprising programming to control providing a measurement signal, comprising data points, related to glucose amount or concentration in a subject, wherein said data points typically have a monotonic trend; and evaluating said data points for one or more non-monotonic event, wherein (i) if the data points have an acceptable monotonic trend the measurement signal is accepted for further processing, or (ii) if the data points comprise one or more non-monotonic events then a percent contribution of said one or more non-monotonic events relative to total measurement signal is further evaluated, wherein if the percent contribution is less than a predetermined threshold value or falls within a predetermined range relative to total measurement signal, then the measurement signal is accepted for further processing; however, if the percent contribution is greater than a predetermined threshold value or falls outside a predetermined range relative to total measurement signal, then the measurement signal is not accepted for further processing and the measurement signal is skipped.
50. The one or more microprocessors of claim 49, wherein said measurement signal comprising data points that typically have a monotonic trend is either a current measurement or a charge measurement.
51. An analyte monitoring system, comprising said one or more microprocessors of any of claims 49-50; and a sensing device used to provide said measurement signal related to glucose amount or concentration.
52. One or more microprocessors, comprising programming to control:
qualifying whether an unusable analyte-related electrochemical current signal from a given measurement cycle should be replaced by interpolation or extrapolation by applying one or more of the following criteria: (i) if a sensor consistency check value for the measurement cycle falls within a predetermined acceptable range or within a predetermined threshold then the corresponding analyte-related signal may be replaced; (ii) if a change in background current for the measurement cycle falls within a predetermined acceptable range or within a predetermined threshold then the corresponding analyte-related signal may be replaced; (iii) if a change in temperature falls within a predetermined acceptable range or within a predetermined threshold then the corresponding analyte-related signal may be replaced; and replacing, in a series of analyte-related signals, an unusable analyte-related signal with an estimated signal by either:
(A) if one or more analyte-related signals previous to the unusable analyte-related signal and one or more analyte-related signals subsequent to the unusable analyte related signal are available, then interpolation is used to estimate the unusable, intervening analyte-related signal, or (B) if two or more analyte-related signals previous to the unusable analyte-related signal are available, then extrapolation is used to estimate the unusable, subsequent analyte-related signal;
wherein said series of analyte-related signals is obtained from an analyte monitoring device over time, and each analyte-related signal is related to an amount or concentration of analyte in a subject being monitored with the analyte monitoring device.
qualifying whether an unusable analyte-related electrochemical current signal from a given measurement cycle should be replaced by interpolation or extrapolation by applying one or more of the following criteria: (i) if a sensor consistency check value for the measurement cycle falls within a predetermined acceptable range or within a predetermined threshold then the corresponding analyte-related signal may be replaced; (ii) if a change in background current for the measurement cycle falls within a predetermined acceptable range or within a predetermined threshold then the corresponding analyte-related signal may be replaced; (iii) if a change in temperature falls within a predetermined acceptable range or within a predetermined threshold then the corresponding analyte-related signal may be replaced; and replacing, in a series of analyte-related signals, an unusable analyte-related signal with an estimated signal by either:
(A) if one or more analyte-related signals previous to the unusable analyte-related signal and one or more analyte-related signals subsequent to the unusable analyte related signal are available, then interpolation is used to estimate the unusable, intervening analyte-related signal, or (B) if two or more analyte-related signals previous to the unusable analyte-related signal are available, then extrapolation is used to estimate the unusable, subsequent analyte-related signal;
wherein said series of analyte-related signals is obtained from an analyte monitoring device over time, and each analyte-related signal is related to an amount or concentration of analyte in a subject being monitored with the analyte monitoring device.
53. The one or more microprocessors of claim 52, wherein said analyte monitoring device comprises a sensing device and said one or more microprocessors are further programmed to control operation of said sensing device.
54. The one or more microprocessors of claim 53, wherein said analyte monitoring device further comprises a sampling device and said one or more microprocessors are further programmed to control operation of said sampling device.
55. An analyte monitoring system, comprising said one or more microprocessors of claim 53; and the sensing device used to provide said analyte-related signals.
56. An analyte monitoring system, comprising said one or more microprocessors of claim 54;
the sampling device; and the sensing device used to provide said analyte-related signals.
the sampling device; and the sensing device used to provide said analyte-related signals.
57. One or more microprocessors, comprising programming to control selecting a current integration method for an analyte-related current signal, wherein said analyte-related current signal comprises data points, a two sensor system is used for detecting said analyte-related current signal, each of said two sensors are electrochemical sensors, each sensor alternately acts as cathode and anode, a current signal, comprising data points, is detected in a half-measurement cycle from the anode and the cathode, and the analyte-related current signal is obtained from the cathode;
determining a background baseline for a given sensor when acting as cathode is determined from the last two data points of the current signal detected for the same sensor in a previous half-cycle when the sensor acted as an anode; and subtracting the background baseline from the analyte-related current signal and if over-subtraction of the analyte-related current signal occurs, employing one of the following integration methods to determine an analyte-related charge signal based on the analyte-related current signal: (i) stopping integration when the maximum integral is reached and using the maximum integral as the analyte-related charge signal;
or (ii) recalculating a background baseline based on the last two data points from the analyte-related current signal at the cathode, subtracting the recalculated background baseline from the analyte-related current signal, and integrating the background subtracted analyte-related current signal to obtain the analyte-related charge signal.
determining a background baseline for a given sensor when acting as cathode is determined from the last two data points of the current signal detected for the same sensor in a previous half-cycle when the sensor acted as an anode; and subtracting the background baseline from the analyte-related current signal and if over-subtraction of the analyte-related current signal occurs, employing one of the following integration methods to determine an analyte-related charge signal based on the analyte-related current signal: (i) stopping integration when the maximum integral is reached and using the maximum integral as the analyte-related charge signal;
or (ii) recalculating a background baseline based on the last two data points from the analyte-related current signal at the cathode, subtracting the recalculated background baseline from the analyte-related current signal, and integrating the background subtracted analyte-related current signal to obtain the analyte-related charge signal.
58. An analyte monitoring system, comprising said one or more microprocessors of claim 57; and a sensing device comprising said two sensor system.
59. The one or more microprocessors of any of claims 52 or 57, wherein the analyze-related signal is related to an amount or concentration of glucose.
60. One or more algorithms to optimize parameters for use in a model that requires optimization of adjustable parameters, said one or more algorithms comprising dividing a data set into a training set and a validation set;
training the model to determine the adjustable parameters using said training set;
stopping said training before the model parameters fully converged; and validating the parameters using the validation set, wherein said validated parameters are optimized parameters for use in the model.
training the model to determine the adjustable parameters using said training set;
stopping said training before the model parameters fully converged; and validating the parameters using the validation set, wherein said validated parameters are optimized parameters for use in the model.
61. The one or more algorithms of claim 60, wherein the model is a Mixtures of Experts (MOE) model.
62. The one or more algorithms of any of claims 60 or 61 wherein the data set comprise measurement values related to an amount or concentration of glucose.
63. One or more algorithms to optimize parameters for use in a prediction model used by an analyte monitoring device, wherein said prediction model requires optimization of adjustable parameters, said one or more algorithms comprising optimizing the parameters based on multiple analyte readings that quantify two or more regions corresponding to various levels of accuracy for the prediction model used by the analyte monitoring device, wherein one or more of the regions have an associated higher risk relative to one or more other regions, such that optimization of the parameters is carried out until error associated with the prediction model is minimized in the regions associated with higher risk.
64. The one or more algorithms of claim 63, wherein said optimizing comprises optimizing a distribution of paired points by (a) constructing an x-y plane of paired points representing (i) a target analyte amount or concentration measured independently as the x coordinate, and (ii) a corresponding model prediction of target analyte amount or concentration as a paired y coordinate, wherein the model is employed by an analyte monitoring device; (b) dividing the x-y plane divided into two or more regions corresponding to various levels of accuracy for the model prediction of the analyte monitoring device; (c) constructing individual mathematical risk functions (F) that assign a numerical value to each paired point (pp) for a particular region;
(d) summing the individual risk functions to provide a total risk function; and (e) minimizing the total risk function resulting in optimized parameters for the model.
(d) summing the individual risk functions to provide a total risk function; and (e) minimizing the total risk function resulting in optimized parameters for the model.
65. The one or more algorithms of any of claims 63 or 64, wherein the model is a Mixtures of Experts (MOE) model.
66. The one or more algorithms of claim 65, wherein the analyte is glucose.
67. The one or more algorithms of claim 64, wherein (i) said two or more regions corresponding to various levels of accuracy for the prediction model comprise a hypoglycemic region, a glucose target range, and a hyperglycemic region, and (ii) said one or more of the regions that have an associated higher risk relative to one or more other regions comprise said hypoglycemic region and said hyperglycemic region.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2738579A CA2738579C (en) | 2002-03-22 | 2003-03-21 | Improving performance of an analyte monitoring device |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36708702P | 2002-03-22 | 2002-03-22 | |
US60/367,087 | 2002-03-22 | ||
US41398902P | 2002-09-25 | 2002-09-25 | |
US60/413,989 | 2002-09-25 | ||
PCT/US2003/008914 WO2003082098A2 (en) | 2002-03-22 | 2003-03-21 | Improving performance of an analyte monitoring device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2738579A Division CA2738579C (en) | 2002-03-22 | 2003-03-21 | Improving performance of an analyte monitoring device |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2480550A1 true CA2480550A1 (en) | 2003-10-09 |
CA2480550C CA2480550C (en) | 2011-07-12 |
Family
ID=28678180
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2738579A Expired - Lifetime CA2738579C (en) | 2002-03-22 | 2003-03-21 | Improving performance of an analyte monitoring device |
CA2480550A Expired - Lifetime CA2480550C (en) | 2002-03-22 | 2003-03-21 | Improving performance of an analyte monitoring device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2738579A Expired - Lifetime CA2738579C (en) | 2002-03-22 | 2003-03-21 | Improving performance of an analyte monitoring device |
Country Status (9)
Country | Link |
---|---|
US (4) | US20030235817A1 (en) |
EP (2) | EP1702561B1 (en) |
JP (5) | JP4083689B2 (en) |
AT (2) | ATE507766T1 (en) |
CA (2) | CA2738579C (en) |
DE (2) | DE60337038D1 (en) |
ES (1) | ES2357318T3 (en) |
HK (2) | HK1074371A1 (en) |
WO (1) | WO2003082098A2 (en) |
Families Citing this family (331)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7192450B2 (en) | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US6862465B2 (en) | 1997-03-04 | 2005-03-01 | Dexcom, Inc. | Device and method for determining analyte levels |
US9155496B2 (en) | 1997-03-04 | 2015-10-13 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
US7899511B2 (en) | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US8527026B2 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
DK1102559T3 (en) | 1998-09-30 | 2003-09-29 | Cygnus Therapeutic Systems | Method and apparatus for predicting physiological values |
US7890295B2 (en) | 2000-02-23 | 2011-02-15 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7316700B2 (en) | 2001-06-12 | 2008-01-08 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
CA2448905C (en) | 2001-06-12 | 2010-09-07 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
ATE485766T1 (en) | 2001-06-12 | 2010-11-15 | Pelikan Technologies Inc | ELECTRICAL ACTUATING ELEMENT FOR A LANCET |
WO2002100254A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
ATE497731T1 (en) | 2001-06-12 | 2011-02-15 | Pelikan Technologies Inc | DEVICE FOR INCREASING THE SUCCESS RATE OF BLOOD YIELD OBTAINED BY A FINGER PICK |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
WO2003000127A2 (en) * | 2001-06-22 | 2003-01-03 | Cygnus, Inc. | Method for improving the performance of an analyte monitoring system |
US20030032874A1 (en) | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9282925B2 (en) | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US6998247B2 (en) * | 2002-03-08 | 2006-02-14 | Sensys Medical, Inc. | Method and apparatus using alternative site glucose determinations to calibrate and maintain noninvasive and implantable analyzers |
EP1702561B1 (en) | 2002-03-22 | 2011-05-04 | Animas Technologies LLC | Improving performance for an analyte monitoring device |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US7226978B2 (en) | 2002-05-22 | 2007-06-05 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
EP1552146B1 (en) | 2002-10-09 | 2011-04-20 | Abbott Diabetes Care Inc. | Fluid delivery device, system and method |
US7727181B2 (en) | 2002-10-09 | 2010-06-01 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
US7993108B2 (en) | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
US7248912B2 (en) * | 2002-10-31 | 2007-07-24 | The Regents Of The University Of California | Tissue implantable sensors for measurement of blood solutes |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
EP1578262A4 (en) | 2002-12-31 | 2007-12-05 | Therasense Inc | Continuous glucose monitoring system and methods of use |
MXPA05010221A (en) * | 2003-03-25 | 2006-02-22 | Terry O Herndon | Drill device and method for forming microconduits. |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US7679407B2 (en) | 2003-04-28 | 2010-03-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
US7875293B2 (en) | 2003-05-21 | 2011-01-25 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
WO2004107964A2 (en) | 2003-06-06 | 2004-12-16 | Pelikan Technologies, Inc. | Blood harvesting device with electronic control |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US7722536B2 (en) | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7761130B2 (en) | 2003-07-25 | 2010-07-20 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
EP1648298A4 (en) | 2003-07-25 | 2010-01-13 | Dexcom Inc | Oxygen enhancing membrane systems for implantable devices |
WO2005012873A2 (en) | 2003-07-25 | 2005-02-10 | Dexcom, Inc. | Electrode systems for electrochemical sensors |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8160669B2 (en) | 2003-08-01 | 2012-04-17 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8626257B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | Analyte sensor |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7986986B2 (en) | 2003-08-01 | 2011-07-26 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8845536B2 (en) | 2003-08-01 | 2014-09-30 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8060173B2 (en) | 2003-08-01 | 2011-11-15 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US20070208245A1 (en) * | 2003-08-01 | 2007-09-06 | Brauker James H | Transcutaneous analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7494465B2 (en) | 2004-07-13 | 2009-02-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8761856B2 (en) | 2003-08-01 | 2014-06-24 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20100168543A1 (en) | 2003-08-01 | 2010-07-01 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for a variable user interface |
US7299082B2 (en) * | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
US20050108103A1 (en) * | 2003-11-18 | 2005-05-19 | Roberts Roland L. | Prospect qualifying calculator |
WO2005051170A2 (en) | 2003-11-19 | 2005-06-09 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US8774886B2 (en) | 2006-10-04 | 2014-07-08 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8425416B2 (en) | 2006-10-04 | 2013-04-23 | Dexcom, Inc. | Analyte sensor |
US8425417B2 (en) | 2003-12-05 | 2013-04-23 | Dexcom, Inc. | Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device |
US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8364230B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
EP2239567B1 (en) | 2003-12-05 | 2015-09-02 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
EP2329763B1 (en) | 2003-12-09 | 2017-06-21 | DexCom, Inc. | Signal processing for continuous analyte sensor |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
BRPI0507376A (en) | 2004-02-06 | 2007-07-10 | Bayer Healthcare Llc | oxidizable species as an internal reference for biosensors and method of use |
WO2005089103A2 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
JP4611372B2 (en) * | 2004-02-26 | 2011-01-12 | ダイアベティス ツールズ スウェーデン アーベー | Metabolic monitoring, method and apparatus for displaying conditions related to the health of a subject |
DE102004020160A1 (en) | 2004-04-24 | 2005-11-10 | Roche Diagnostics Gmbh | Method and device for monitoring a concentration of an analyte in the living body of a human or animal |
US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | Method and apparatus for a fluid sampling device |
CA2572455C (en) | 2004-06-04 | 2014-10-28 | Therasense, Inc. | Diabetes care host-client architecture and data management system |
US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8565848B2 (en) | 2004-07-13 | 2013-10-22 | Dexcom, Inc. | Transcutaneous analyte sensor |
EP3524142B1 (en) | 2004-07-13 | 2021-04-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7310544B2 (en) | 2004-07-13 | 2007-12-18 | Dexcom, Inc. | Methods and systems for inserting a transcutaneous analyte sensor |
US20060270922A1 (en) | 2004-07-13 | 2006-11-30 | Brauker James H | Analyte sensor |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US7857760B2 (en) | 2004-07-13 | 2010-12-28 | Dexcom, Inc. | Analyte sensor |
US7719523B2 (en) | 2004-08-06 | 2010-05-18 | Touchtable, Inc. | Bounding box gesture recognition on a touch detecting interactive display |
US7724242B2 (en) | 2004-08-06 | 2010-05-25 | Touchtable, Inc. | Touch driven method and apparatus to integrate and display multiple image layers forming alternate depictions of same subject matter |
US7728821B2 (en) * | 2004-08-06 | 2010-06-01 | Touchtable, Inc. | Touch detecting interactive display |
JP2006147472A (en) * | 2004-11-24 | 2006-06-08 | Olympus Corp | Energy generator using substance originated from living body |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
US20060200070A1 (en) | 2005-02-14 | 2006-09-07 | Callicoat David N | Method and apparatus for calibrating an analyte detection system with a calibration sample |
US20090076360A1 (en) | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
EP1863559A4 (en) | 2005-03-21 | 2008-07-30 | Abbott Diabetes Care Inc | Method and system for providing integrated medication infusion and analyte monitoring system |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
US8060174B2 (en) | 2005-04-15 | 2011-11-15 | Dexcom, Inc. | Analyte sensing biointerface |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US7620437B2 (en) | 2005-06-03 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
KR101477815B1 (en) | 2005-09-30 | 2015-01-02 | 바이엘 헬스케어 엘엘씨 | Gated voltammetry |
US7756561B2 (en) | 2005-09-30 | 2010-07-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
WO2007053963A1 (en) * | 2005-11-10 | 2007-05-18 | Solianis Holding Ag | Device for determining the glucose level in body tissue |
US7729737B2 (en) * | 2005-11-22 | 2010-06-01 | Isense Corporation | Method and apparatus for background current arrangements for a biosensor |
US20070207516A1 (en) * | 2005-12-21 | 2007-09-06 | Doupe Thomas H | Cholesterol measurement system and method |
US7985330B2 (en) * | 2005-12-30 | 2011-07-26 | Medtronic Minimed, Inc. | Method and system for detecting age, hydration, and functional states of sensors using electrochemical impedance spectroscopy |
US20070173712A1 (en) * | 2005-12-30 | 2007-07-26 | Medtronic Minimed, Inc. | Method of and system for stabilization of sensors |
US20070169533A1 (en) | 2005-12-30 | 2007-07-26 | Medtronic Minimed, Inc. | Methods and systems for detecting the hydration of sensors |
US9757061B2 (en) | 2006-01-17 | 2017-09-12 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US8344966B2 (en) | 2006-01-31 | 2013-01-01 | Abbott Diabetes Care Inc. | Method and system for providing a fault tolerant display unit in an electronic device |
EP1991110B1 (en) | 2006-03-09 | 2018-11-07 | DexCom, Inc. | Systems and methods for processing analyte sensor data |
US7653425B2 (en) * | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US7630748B2 (en) | 2006-10-25 | 2009-12-08 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US8224415B2 (en) | 2009-01-29 | 2012-07-17 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
WO2007120381A2 (en) | 2006-04-14 | 2007-10-25 | Dexcom, Inc. | Analyte sensor |
WO2007133985A2 (en) | 2006-05-08 | 2007-11-22 | Bayer Healthcare Llc | Abnormal output detection system for a biosensor |
US20080071158A1 (en) | 2006-06-07 | 2008-03-20 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
US8447376B2 (en) | 2006-10-04 | 2013-05-21 | Dexcom, Inc. | Analyte sensor |
US8562528B2 (en) | 2006-10-04 | 2013-10-22 | Dexcom, Inc. | Analyte sensor |
US8275438B2 (en) | 2006-10-04 | 2012-09-25 | Dexcom, Inc. | Analyte sensor |
US8298142B2 (en) | 2006-10-04 | 2012-10-30 | Dexcom, Inc. | Analyte sensor |
US8478377B2 (en) | 2006-10-04 | 2013-07-02 | Dexcom, Inc. | Analyte sensor |
US7831287B2 (en) | 2006-10-04 | 2010-11-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8449464B2 (en) | 2006-10-04 | 2013-05-28 | Dexcom, Inc. | Analyte sensor |
EP2080022B1 (en) * | 2006-10-05 | 2015-05-13 | Lifescan Scotland Ltd | Methods for determining an analyte concentration using signal processing algorithms |
US9046480B2 (en) | 2006-10-05 | 2015-06-02 | Lifescan Scotland Limited | Method for determining hematocrit corrected analyte concentrations |
US8579853B2 (en) | 2006-10-31 | 2013-11-12 | Abbott Diabetes Care Inc. | Infusion devices and methods |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
EP2146625B1 (en) | 2007-04-14 | 2019-08-14 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8597190B2 (en) | 2007-05-18 | 2013-12-03 | Optiscan Biomedical Corporation | Monitoring systems and methods with fast initialization |
EP2156348B1 (en) | 2007-05-30 | 2018-08-01 | Ascensia Diabetes Care Holdings AG | System and method for managing health data |
EP2152350A4 (en) | 2007-06-08 | 2013-03-27 | Dexcom Inc | Integrated medicament delivery device for use with continuous analyte sensor |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US8088272B2 (en) * | 2007-07-26 | 2012-01-03 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
US8101062B2 (en) * | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
EP2197521B1 (en) * | 2007-08-31 | 2016-04-13 | Leon Dejournett | Computerized blood glucose level adjustment system |
PL2040072T3 (en) | 2007-09-22 | 2013-06-28 | Hoffmann La Roche | Analysis system for measuring the concentration of an analyte in a bodily fluid |
EP2227132B1 (en) | 2007-10-09 | 2023-03-08 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
DE502007004737D1 (en) * | 2007-10-16 | 2010-09-23 | Roche Diagnostics Gmbh | Method for storing a measurement series |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7783442B2 (en) * | 2007-10-31 | 2010-08-24 | Medtronic Minimed, Inc. | System and methods for calibrating physiological characteristic sensors |
WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8229535B2 (en) | 2008-02-21 | 2012-07-24 | Dexcom, Inc. | Systems and methods for blood glucose monitoring and alert delivery |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8583204B2 (en) | 2008-03-28 | 2013-11-12 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8682408B2 (en) | 2008-03-28 | 2014-03-25 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
EP2106784B1 (en) * | 2008-04-03 | 2015-04-22 | Rohm and Haas Company | Hair styling composition |
EP2265324B1 (en) | 2008-04-11 | 2015-01-28 | Sanofi-Aventis Deutschland GmbH | Integrated analyte measurement system |
KR20090118314A (en) * | 2008-05-13 | 2009-11-18 | 케이엠에이치 주식회사 | A apparatus and method for measuring a blood glucose using a electrophoresis phenomenon without blood gathering |
US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8262899B2 (en) | 2008-07-10 | 2012-09-11 | Bayer Healthcare Llc | Systems and methods including amperometric and voltammetric duty cycles |
CN102105103B (en) * | 2008-07-31 | 2015-09-09 | 希森美康株式会社 | The in vivo assay method of composition, for the data processing method of in vivo composition measurement, in vivo component measuring device and collecting part |
EP4227675A3 (en) | 2008-09-19 | 2023-09-06 | DexCom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
US9326707B2 (en) | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
KR101285520B1 (en) * | 2008-12-23 | 2013-07-17 | 에프. 호프만-라 로슈 아게 | Structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof |
US10437962B2 (en) | 2008-12-23 | 2019-10-08 | Roche Diabetes Care Inc | Status reporting of a structured collection procedure |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US8560082B2 (en) | 2009-01-30 | 2013-10-15 | Abbott Diabetes Care Inc. | Computerized determination of insulin pump therapy parameters using real time and retrospective data processing |
US20100219085A1 (en) * | 2009-02-27 | 2010-09-02 | Edwards Lifesciences Corporation | Analyte Sensor Offset Normalization |
WO2010111660A1 (en) | 2009-03-27 | 2010-09-30 | Dexcom, Inc. | Methods and systems for promoting glucose management |
JP5367598B2 (en) * | 2009-03-30 | 2013-12-11 | シスメックス株式会社 | Method and apparatus for estimating concentration fluctuation of measurement target component in blood using area under blood concentration-time curve |
US8467972B2 (en) | 2009-04-28 | 2013-06-18 | Abbott Diabetes Care Inc. | Closed loop blood glucose control algorithm analysis |
WO2010127050A1 (en) | 2009-04-28 | 2010-11-04 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
WO2010127169A2 (en) | 2009-04-30 | 2010-11-04 | Dexcom, Inc. | Performance reports associated with continuous sensor data from multiple analysis time periods |
WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
WO2010151592A1 (en) | 2009-06-23 | 2010-12-29 | Bayer Healthcare Llc | System and apparatus for determining temperatures in a fluid analyte system |
US9351677B2 (en) | 2009-07-02 | 2016-05-31 | Dexcom, Inc. | Analyte sensor with increased reference capacity |
US9237864B2 (en) | 2009-07-02 | 2016-01-19 | Dexcom, Inc. | Analyte sensors and methods of manufacturing same |
ES2888427T3 (en) | 2009-07-23 | 2022-01-04 | Abbott Diabetes Care Inc | Real-time management of data related to the physiological control of glucose levels |
EP3689237B1 (en) | 2009-07-23 | 2021-05-19 | Abbott Diabetes Care, Inc. | Method of manufacturing and system for continuous analyte measurement |
ES2952361T3 (en) | 2009-08-31 | 2023-10-31 | Abbott Diabetes Care Inc | Displays for a medical device |
EP2473098A4 (en) | 2009-08-31 | 2014-04-09 | Abbott Diabetes Care Inc | Analyte signal processing device and methods |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
WO2011041469A1 (en) | 2009-09-29 | 2011-04-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
EP2494323A4 (en) | 2009-10-30 | 2014-07-16 | Abbott Diabetes Care Inc | Method and apparatus for detecting false hypoglycemic conditions |
KR101100987B1 (en) * | 2010-03-23 | 2011-12-30 | 삼성모바일디스플레이주식회사 | Touch Screen Panel |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
WO2011156522A1 (en) | 2010-06-09 | 2011-12-15 | Optiscan Biomedical Corporation | Measuring analytes in a fluid sample drawn from a patient |
WO2011156095A2 (en) | 2010-06-10 | 2011-12-15 | The Regents Of The University Of California | Textile-based printable electrodes for electrochemical sensing |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
US9052278B2 (en) | 2010-07-19 | 2015-06-09 | Cilag Gmbh International | System and method for measuring an analyte in a sample |
US8748191B2 (en) * | 2010-08-02 | 2014-06-10 | Ecolab Usa Inc. | Stop-flow analytical systems and methods |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
WO2012134890A1 (en) * | 2011-03-25 | 2012-10-04 | Cilag Gmbh International | System and method for measuring an analyte in a sample and correcting for interferents |
CN103477215B (en) | 2011-04-13 | 2015-07-29 | 3M创新有限公司 | Detect the method for volatile organic compounds |
JP2014510933A (en) | 2011-04-13 | 2014-05-01 | スリーエム イノベイティブ プロパティズ カンパニー | Vapor sensor including sensor element and integrated heating mechanism |
CN103492872B (en) | 2011-04-13 | 2016-04-06 | 3M创新有限公司 | Use the method for absorbability sensor element |
WO2012142502A2 (en) | 2011-04-15 | 2012-10-18 | Dexcom Inc. | Advanced analyte sensor calibration and error detection |
US8868217B2 (en) * | 2011-06-27 | 2014-10-21 | Bioness Neuromodulation Ltd. | Electrode for muscle stimulation |
JP6321540B2 (en) | 2011-07-26 | 2018-05-09 | グリセンス インコーポレイテッド | Implantable analyte sensor with hermetically sealed housing and method of manufacturing the sensor |
US8560251B2 (en) * | 2011-08-16 | 2013-10-15 | Instrumentation Laboratory Company | System and method of increasing sample throughput by estimation of a sensor endpoint |
ES2608592T3 (en) | 2011-08-16 | 2017-04-12 | Instrumentation Laboratory Company | Extrapolation of data from interpolated sensors to increase sample throughput |
RU2602040C2 (en) * | 2011-08-26 | 2016-11-10 | Университи Оф Вирджиния Патент Фоундэйшион | Method, system and computer readable medium for adaptive advisory control of diabetes |
US9622691B2 (en) | 2011-10-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
US9989522B2 (en) * | 2011-11-01 | 2018-06-05 | Medtronic Minimed, Inc. | Methods and materials for modulating start-up time and air removal in dry sensors |
WO2013070794A2 (en) | 2011-11-07 | 2013-05-16 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
EP2791667B1 (en) | 2011-12-13 | 2018-03-28 | 3M Innovative Properties Company | Method for identification and quantitative determination of an unknown organic compound in a gaseous medium |
EP2657681A1 (en) | 2012-04-26 | 2013-10-30 | Roche Diagnostics GmbH | Improvement of the sensitivity and the dynamic range of photometric assays by generating multiple calibration curves |
GB2502287B (en) * | 2012-05-21 | 2016-11-23 | Dermal Diagnostics Ltd | Cumulative measurement of an analyte |
US10660550B2 (en) | 2015-12-29 | 2020-05-26 | Glysens Incorporated | Implantable sensor apparatus and methods |
US10561353B2 (en) | 2016-06-01 | 2020-02-18 | Glysens Incorporated | Biocompatible implantable sensor apparatus and methods |
US10132793B2 (en) | 2012-08-30 | 2018-11-20 | Abbott Diabetes Care Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US20140088372A1 (en) * | 2012-09-25 | 2014-03-27 | Google Inc. | Information processing method |
EP2901153A4 (en) | 2012-09-26 | 2016-04-27 | Abbott Diabetes Care Inc | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US10463282B2 (en) * | 2012-10-04 | 2019-11-05 | Roche Diabetes Care, Inc. | System and method for assessing risk associated with a glucose state |
US10335075B2 (en) | 2013-03-14 | 2019-07-02 | Dexcom, Inc. | Advanced calibration for analyte sensors |
US10076285B2 (en) | 2013-03-15 | 2018-09-18 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
EP2811300A1 (en) * | 2013-06-07 | 2014-12-10 | Roche Diagniostics GmbH | Calibration for multi-component assays |
US9778219B2 (en) | 2013-11-27 | 2017-10-03 | Delphi Technologies, Inc. | Electrochemical detection system and method of operation |
US20170185748A1 (en) | 2014-03-30 | 2017-06-29 | Abbott Diabetes Care Inc. | Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems |
GB201406257D0 (en) * | 2014-04-07 | 2014-05-21 | Univ City | System & method for estimating substance concentrations in bodily fluids |
WO2016036944A1 (en) * | 2014-09-03 | 2016-03-10 | Echo Therapeutics, Inc. | Transdermal analyte monitoring systems corrected for on-skin and break-in currents |
WO2016090189A1 (en) * | 2014-12-03 | 2016-06-09 | The Regents Of The University Of California | Non-invasive and wearable chemical sensors and biosensors |
US11330987B2 (en) | 2015-04-06 | 2022-05-17 | Thomas Jefferson University | Implantable vital sign sensor |
US11000195B2 (en) | 2015-04-06 | 2021-05-11 | Thomas Jefferson University | Implantable vital sign sensor |
US10335043B2 (en) | 2015-04-06 | 2019-07-02 | Thomas Jefferson University | Implantable vital sign sensor |
US10413200B2 (en) | 2015-04-06 | 2019-09-17 | Thomas Jefferson University | Implantable vital sign sensor |
US11553883B2 (en) | 2015-07-10 | 2023-01-17 | Abbott Diabetes Care Inc. | System, device and method of dynamic glucose profile response to physiological parameters |
WO2017020019A1 (en) * | 2015-07-29 | 2017-02-02 | Parker-Hannifin Corporation | Solid-state electrodes and sensors having redox active surface areas |
US20170065231A1 (en) * | 2015-09-04 | 2017-03-09 | Goldensunda Technology Co., Ltd. | Noninvasive blood sugar measurement device |
US20170103166A1 (en) * | 2015-10-13 | 2017-04-13 | Sk Planet Co., Ltd. | Wearable device for providing service according to measurement of blood alcohol level and management server therefor |
CN105388276B (en) * | 2016-01-01 | 2017-08-04 | 河南科技大学第一附属医院 | A kind of Blood Kit analysis system and analysis method |
WO2017190143A1 (en) | 2016-04-29 | 2017-11-02 | Senseonics, Incorporated | Real-time denoising and prediction for a continuous glucose monitoring system |
US10638962B2 (en) | 2016-06-29 | 2020-05-05 | Glysens Incorporated | Bio-adaptable implantable sensor apparatus and methods |
JP6778058B2 (en) * | 2016-08-31 | 2020-10-28 | シスメックス株式会社 | Sensor assembly, test substance monitoring system and test substance monitoring method |
CN107788965A (en) * | 2016-09-05 | 2018-03-13 | 京东方科技集团股份有限公司 | A kind of determination method and device of blood pressure |
KR102619443B1 (en) * | 2016-09-30 | 2023-12-28 | 삼성전자주식회사 | Wrist temperature rhythm acquisition apparatus and method, core temperature rhythm acquisition apparatus and method, wearable device |
GB2560203B (en) * | 2017-03-03 | 2021-10-27 | Zwipe As | Smartcard |
WO2018175489A1 (en) | 2017-03-21 | 2018-09-27 | Abbott Diabetes Care Inc. | Methods, devices and system for providing diabetic condition diagnosis and therapy |
US10638979B2 (en) | 2017-07-10 | 2020-05-05 | Glysens Incorporated | Analyte sensor data evaluation and error reduction apparatus and methods |
KR102003667B1 (en) * | 2017-08-21 | 2019-07-25 | 포항공과대학교 산학협력단 | Apparatus, method, and program for predicting hypoglycemia, and apparatus, method, and program for generating hypoglycemia prediction model |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
CA3077720A1 (en) | 2017-10-24 | 2019-05-02 | Dexcom, Inc. | Pre-connected analyte sensors |
CN111263958B (en) * | 2017-10-30 | 2022-05-27 | 开利公司 | Compensator in detector device |
US11278668B2 (en) | 2017-12-22 | 2022-03-22 | Glysens Incorporated | Analyte sensor and medicant delivery data evaluation and error reduction apparatus and methods |
US10244985B1 (en) * | 2017-12-28 | 2019-04-02 | Saleem Sayani | Wearable diagnostic device |
US11255839B2 (en) | 2018-01-04 | 2022-02-22 | Glysens Incorporated | Apparatus and methods for analyte sensor mismatch correction |
KR102035424B1 (en) * | 2018-06-20 | 2019-10-22 | 울산과학기술원 | Calibration method of glucose sensing apparatus |
EP3920798A1 (en) | 2019-02-05 | 2021-12-15 | Ascensia Diabetes Care Holdings AG | Apparatus and methods for probing sensor operation of continuous analyte sensing and auto-calibration |
JP2022521409A (en) | 2019-02-22 | 2022-04-07 | アセンシア・ディアベティス・ケア・ホールディングス・アーゲー | Method and device for monitoring the concentration of the object to be analyzed using harmonic relations |
WO2021046477A1 (en) * | 2019-09-04 | 2021-03-11 | The Brigham And Women's Hospital, Inc. | Systems and methods for assessing outcomes of the combination of predictive or descriptive data models |
US20210068724A1 (en) * | 2019-09-10 | 2021-03-11 | Ascensia Diabetes Care Holdings Ag | Methods and apparatus for information gathering, error detection and analyte concentration determination during continuous analyte sensing |
RU197895U1 (en) * | 2020-02-05 | 2020-06-04 | Общество с ограниченной ответственностью "МедТехПродукт" | ELECTROCHEMICAL BIOSENSOR FOR DETERMINING BLOOD Glucose Concentration |
CN111338275B (en) * | 2020-02-21 | 2022-04-12 | 中科维卡(苏州)自动化科技有限公司 | Method and system for monitoring running state of electrical equipment |
CN113545776A (en) * | 2020-04-16 | 2021-10-26 | 智准生医科技股份有限公司 | Biological information measurement system and biological information correction method |
DK4048152T3 (en) | 2020-07-29 | 2024-03-11 | Biolinq Incorporated | SYSTEM FOR CONTINUOUS ANALYTE MONITORING WITH MICRON NEEDLE ARRANGEMENT |
CN116113454A (en) | 2021-05-08 | 2023-05-12 | 比奥林股份有限公司 | Continuous analyte monitoring device fault detection based on microneedle arrays |
WO2023091042A1 (en) * | 2021-11-16 | 2023-05-25 | Общество С Ограниченной Ответственностью Инжиниринговый Центр Миэт | Method and device for measuring physiological parameters of cattle |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4325367A (en) | 1977-06-13 | 1982-04-20 | Robert Tapper | Iontophoretic treatment apparatus |
WO1989006989A1 (en) | 1988-01-29 | 1989-08-10 | The Regents Of The University Of California | Iontophoretic non-invasive sampling or delivery device |
US5362307A (en) | 1989-01-24 | 1994-11-08 | The Regents Of The University Of California | Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance |
US5062841A (en) | 1988-08-12 | 1991-11-05 | The Regents Of The University Of California | Implantable, self-regulating mechanochemical insulin pump |
US5086229A (en) | 1989-01-19 | 1992-02-04 | Futrex, Inc. | Non-invasive measurement of blood glucose |
US4975581A (en) | 1989-06-21 | 1990-12-04 | University Of New Mexico | Method of and apparatus for determining the similarity of a biological analyte from a model constructed from known biological fluids |
CH677149A5 (en) * | 1989-07-07 | 1991-04-15 | Disetronic Ag | |
US5112614A (en) | 1989-09-14 | 1992-05-12 | Alza Corporation | Implantable delivery dispenser |
CA2028261C (en) | 1989-10-28 | 1995-01-17 | Won Suck Yang | Non-invasive method and apparatus for measuring blood glucose concentration |
US5115805A (en) | 1990-02-23 | 1992-05-26 | Cygnus Therapeutic Systems | Ultrasound-enhanced delivery of materials into and through the skin |
US5771890A (en) | 1994-06-24 | 1998-06-30 | Cygnus, Inc. | Device and method for sampling of substances using alternating polarity |
CA2193885C (en) | 1994-06-24 | 2003-11-25 | Janet Tamada | Iontophoretic sampling device and method |
US5995860A (en) | 1995-07-06 | 1999-11-30 | Thomas Jefferson University | Implantable sensor and system for measurement and control of blood constituent levels |
DK0840597T3 (en) | 1995-07-12 | 2004-01-26 | Cygnus Therapeutic Systems | hydrogel |
US5989409A (en) | 1995-09-11 | 1999-11-23 | Cygnus, Inc. | Method for glucose sensing |
US5735273A (en) | 1995-09-12 | 1998-04-07 | Cygnus, Inc. | Chemical signal-impermeable mask |
JP3316820B2 (en) | 1995-12-28 | 2002-08-19 | シィグナス インコーポレィティド | Apparatus and method for continuous monitoring of a physiological analyte of a subject |
US5747806A (en) | 1996-02-02 | 1998-05-05 | Instrumentation Metrics, Inc | Method and apparatus for multi-spectral analysis in noninvasive nir spectroscopy |
US5962215A (en) | 1996-04-05 | 1999-10-05 | Mercury Diagnostics, Inc. | Methods for testing the concentration of an analyte in a body fluid |
IL124510A0 (en) | 1996-05-17 | 1998-12-06 | Mercury Diagnostics Inc | Disposable element for use in a body fluid sampling device |
EP2160981B1 (en) | 1996-05-17 | 2013-04-10 | Roche Diagnostics Operations, Inc. | Apparatus for expressing body fluid from an incision |
US5954685A (en) | 1996-05-24 | 1999-09-21 | Cygnus, Inc. | Electrochemical sensor with dual purpose electrode |
US5892661A (en) | 1996-10-31 | 1999-04-06 | Motorola, Inc. | Smartcard and method of making |
US6139718A (en) | 1997-03-25 | 2000-10-31 | Cygnus, Inc. | Electrode with improved signal to noise ratio |
US6579690B1 (en) | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
WO1999040848A1 (en) | 1998-02-17 | 1999-08-19 | Abbott Laboratories | Interstitial fluid collection and monitoring device |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
ATE375752T1 (en) | 1998-03-06 | 2007-11-15 | Spectrx Inc | INTEGRATED TISSUE PORATION, FLUID COLLECTION AND ANALYSIS DEVICE |
US6587705B1 (en) | 1998-03-13 | 2003-07-01 | Lynn Kim | Biosensor, iontophoretic sampling system, and methods of use thereof |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
CA2311487C (en) | 1998-05-13 | 2004-02-10 | Cygnus, Inc. | Signal processing for measurement of physiological analytes |
CA2329411C (en) | 1998-05-13 | 2004-01-27 | Cygnus, Inc. | Collection assemblies for transdermal sampling system |
US6272364B1 (en) * | 1998-05-13 | 2001-08-07 | Cygnus, Inc. | Method and device for predicting physiological values |
CA2332112C (en) | 1998-05-13 | 2004-02-10 | Cygnus, Inc. | Monitoring of physiological analytes |
DE69913153D1 (en) | 1998-09-17 | 2004-01-08 | Cygnus Therapeutic Systems | DEVICE FOR COMPRESSING A GEL / SENSOR UNIT |
DK1102559T3 (en) | 1998-09-30 | 2003-09-29 | Cygnus Therapeutic Systems | Method and apparatus for predicting physiological values |
US6180416B1 (en) * | 1998-09-30 | 2001-01-30 | Cygnus, Inc. | Method and device for predicting physiological values |
US6391643B1 (en) | 1998-10-28 | 2002-05-21 | Cygnus, Inc. | Kit and method for quality control testing of an iontophoretic sampling system |
CA2365609A1 (en) | 1999-02-12 | 2000-08-17 | Cygnus, Inc. | Devices and methods for frequent measurement of an analyte present in a biological system |
JP2002542498A (en) | 1999-04-22 | 2002-12-10 | シグナス, インコーポレイテッド | Methods and devices for removing interfering species |
DE10029010B4 (en) * | 1999-06-22 | 2008-06-05 | Toyota Jidosha Kabushiki Kaisha, Toyota | Device for controlling suspension shock absorbers in vehicles based on a bilayer damping system |
WO2001088534A2 (en) * | 2000-05-16 | 2001-11-22 | Cygnus, Inc. | Methods for improving performance and reliability of biosensors |
WO2002015778A1 (en) | 2000-08-18 | 2002-02-28 | Cygnus, Inc. | Analyte monitoring device alarm augmentation system |
US6633772B2 (en) | 2000-08-18 | 2003-10-14 | Cygnus, Inc. | Formulation and manipulation of databases of analyte and associated values |
CA2408338C (en) | 2000-08-18 | 2009-09-08 | Cygnus, Inc. | Methods and devices for prediction of hypoglycemic events |
US20020026111A1 (en) | 2000-08-28 | 2002-02-28 | Neil Ackerman | Methods of monitoring glucose levels in a subject and uses thereof |
WO2003000127A2 (en) * | 2001-06-22 | 2003-01-03 | Cygnus, Inc. | Method for improving the performance of an analyte monitoring system |
EP1702561B1 (en) | 2002-03-22 | 2011-05-04 | Animas Technologies LLC | Improving performance for an analyte monitoring device |
US7001630B2 (en) * | 2002-08-14 | 2006-02-21 | Danisco A/S | Animal protein-containing food products having improved moisture retention and method of preparing |
US20080014064A1 (en) | 2006-07-14 | 2008-01-17 | Charles Dixon | Bottled water dispenser |
-
2003
- 2003-03-21 EP EP06076174A patent/EP1702561B1/en not_active Expired - Lifetime
- 2003-03-21 US US10/394,516 patent/US20030235817A1/en not_active Abandoned
- 2003-03-21 EP EP03716792A patent/EP1489961B1/en not_active Expired - Lifetime
- 2003-03-21 ES ES03716792T patent/ES2357318T3/en not_active Expired - Lifetime
- 2003-03-21 CA CA2738579A patent/CA2738579C/en not_active Expired - Lifetime
- 2003-03-21 CA CA2480550A patent/CA2480550C/en not_active Expired - Lifetime
- 2003-03-21 AT AT06076174T patent/ATE507766T1/en not_active IP Right Cessation
- 2003-03-21 AT AT03716792T patent/ATE482649T1/en not_active IP Right Cessation
- 2003-03-21 WO PCT/US2003/008914 patent/WO2003082098A2/en active Application Filing
- 2003-03-21 DE DE60337038T patent/DE60337038D1/en not_active Expired - Lifetime
- 2003-03-21 DE DE60334365T patent/DE60334365D1/en not_active Expired - Lifetime
- 2003-03-21 JP JP2003579647A patent/JP4083689B2/en not_active Expired - Fee Related
-
2005
- 2005-06-29 HK HK05105451.6A patent/HK1074371A1/en not_active IP Right Cessation
- 2005-11-09 US US11/270,857 patent/US7523004B2/en not_active Expired - Lifetime
- 2005-11-09 US US11/270,856 patent/US7711493B2/en active Active
- 2005-11-09 US US11/270,063 patent/US7519478B2/en not_active Expired - Lifetime
-
2006
- 2006-10-18 HK HK06111412.1A patent/HK1090532A1/en not_active IP Right Cessation
-
2007
- 2007-06-05 JP JP2007149674A patent/JP4574646B2/en not_active Expired - Fee Related
- 2007-06-05 JP JP2007149679A patent/JP4574647B2/en not_active Expired - Fee Related
- 2007-06-05 JP JP2007149655A patent/JP4615547B2/en not_active Expired - Lifetime
- 2007-06-05 JP JP2007149668A patent/JP4588742B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2480550A1 (en) | Improving performance of an analyte monitoring device | |
JP6448504B2 (en) | Slope-based correction | |
EP2193367B1 (en) | Method for correcting erroneous results of measurement in biosensors and apparatus using the same | |
EP2577303B1 (en) | Underfill management system for a biosensor | |
US8744776B2 (en) | Method for determining analyte concentration based on complex index functions | |
KR102095959B1 (en) | Artificial Neural Network Model-Based Methods for Analyte Analysis | |
US11060978B2 (en) | Methods of determining an analyte concentration in a body fluid sample having disturbance variables, as well as computer programs and devices therefor | |
JP2011506966A5 (en) | ||
CA2667982A1 (en) | Analyte sensors and methods | |
WO2004081524B1 (en) | Measurement site dependent data preprocessing method for robust calibration and prediction | |
RU2007140372A (en) | DEVICE AND METHOD FOR FORECASTING HUMAN TEMPERATURE | |
CN107636452B (en) | Improved biosensor system analyte measurement | |
US20160022172A1 (en) | Systems and methods for fluid testing | |
Ciepiela et al. | Self‐Referencing Background Correction Method for Voltammetric Investigation of Reversible Redox Reaction | |
CN117412708A (en) | Method for determining the current glucose value in a transport fluid | |
JPH116808A (en) | Analytical method in x-ray photoelectron spectroscopic method | |
Almhofer | Entwicklung eines computergestutzten Detektionssystems zur durchflubanalytischen Bestimmung von Sulfat-und Nitrationen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20230321 |